...
qnrx-img

Quoin Pharmaceuticals Ltd DRC, Common Stock

QNRX

NAQ

$0.77

+$0.04

(5.47%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$3.94M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
403.77K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.89
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.48 L
$5.33 H
$0.77

About Quoin Pharmaceuticals Ltd DRC, Common Stock

Quoin Pharmaceuticals, Ltd., a clinical stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases. Its lead product is QRX003, a topical lotion to treat Netherton Syndrome (NS). The company is also developing QRX004 for the treatment of recessive dystrophic epidermolysis bullosa; QRX007 to treat NS; and QRX008 for the treatment of scleroderma. It has a research agreement with Queensland University of Technology; a license agreement with Skinvisible Inc.; consulting agreements with Axella Research LLC; and a Master Service Agreement with Therapeutics Inc. The company was founded in 2018 and is based in Ashburn, Virginia. Quoin Pharmaceuticals, Ltd. operates as a subsidiary of Skinvisible, Inc. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameQNRXSectorS&P500
1-Week Return-4.93%-1.8%-0.77%
1-Month Return20.31%-3.48%0.71%
3-Month Return13.67%-7.2%8.81%
6-Month Return4.21%-1.54%12.32%
1-Year Return-83.76%8.39%30.57%
3-Year Return-99.84%6.07%29.21%
5-Year Return-99.94%44.07%91.95%
10-Year Return-99.99%106.3%196.04%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue227.06K104.77K104.11K103.64K103.44K[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":46.14,"profit":true},{"date":"2021-12-31","value":45.85,"profit":true},{"date":"2022-12-31","value":45.64,"profit":true},{"date":"2023-12-31","value":45.56,"profit":true}]
Gross Profit(227.06K)(104.77K)(104.11K)(103.64K)(103.44K)[{"date":"2019-12-31","value":-22705500,"profit":false},{"date":"2020-12-31","value":-10477300,"profit":false},{"date":"2021-12-31","value":-10411500,"profit":false},{"date":"2022-12-31","value":-10363500,"profit":false},{"date":"2023-12-31","value":-10343800,"profit":false}]
Gross Margin(Infinity%)(Infinity%)(Infinity%)(Infinity%)(Infinity%)[{"date":"2019-12-31","value":null,"profit":false},{"date":"2020-12-31","value":null,"profit":false},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false}]
Operating Expenses1.56M1.67M6.06M9.26M9.38M[{"date":"2019-12-31","value":16.64,"profit":true},{"date":"2020-12-31","value":17.81,"profit":true},{"date":"2021-12-31","value":64.65,"profit":true},{"date":"2022-12-31","value":98.71,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(1.56M)(2.05M)(20.37M)(8.85M)(9.38M)[{"date":"2019-12-31","value":-156040100,"profit":false},{"date":"2020-12-31","value":-204834300,"profit":false},{"date":"2021-12-31","value":-2037217900,"profit":false},{"date":"2022-12-31","value":-884869500,"profit":false},{"date":"2023-12-31","value":-937850400,"profit":false}]
Total Non-Operating Income/Expense1.55M(472.38K)(2.46M)(742.13K)1.33M[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-30.47,"profit":false},{"date":"2021-12-31","value":-158.4,"profit":false},{"date":"2022-12-31","value":-47.87,"profit":false},{"date":"2023-12-31","value":85.85,"profit":true}]
Pre-Tax Income(1.56M)(2.10M)(21.46M)(9.38M)(8.66M)[{"date":"2019-12-31","value":-156040100,"profit":false},{"date":"2020-12-31","value":-209536400,"profit":false},{"date":"2021-12-31","value":-2146258800,"profit":false},{"date":"2022-12-31","value":-938149600,"profit":false},{"date":"2023-12-31","value":-866418900,"profit":false}]
Income Taxes1.55M(331.31K)(12.94M)(104.04K)22.38K[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-21.37,"profit":false},{"date":"2021-12-31","value":-834.89,"profit":false},{"date":"2022-12-31","value":-6.71,"profit":false},{"date":"2023-12-31","value":1.44,"profit":true}]
Income After Taxes(3.11M)(1.76M)(8.52M)(9.28M)(8.69M)[{"date":"2019-12-31","value":-311077600,"profit":false},{"date":"2020-12-31","value":-176405200,"profit":false},{"date":"2021-12-31","value":-851866800,"profit":false},{"date":"2022-12-31","value":-927745300,"profit":false},{"date":"2023-12-31","value":-868657300,"profit":false}]
Income From Continuous Operations(1.56M)(2.10M)(21.46M)(9.38M)(8.64M)[{"date":"2019-12-31","value":-156040100,"profit":false},{"date":"2020-12-31","value":-209536400,"profit":false},{"date":"2021-12-31","value":-2146258800,"profit":false},{"date":"2022-12-31","value":-938149600,"profit":false},{"date":"2023-12-31","value":-863765500,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(1.56M)(1.76M)(8.52M)(9.28M)(8.69M)[{"date":"2019-12-31","value":-156040100,"profit":false},{"date":"2020-12-31","value":-176405200,"profit":false},{"date":"2021-12-31","value":-851866800,"profit":false},{"date":"2022-12-31","value":-927745300,"profit":false},{"date":"2023-12-31","value":-868657300,"profit":false}]
EPS (Diluted)(6.91)(0.10)(315.89)(7.09)(6.50)[{"date":"2019-12-31","value":-690.69,"profit":false},{"date":"2020-12-31","value":-10,"profit":false},{"date":"2021-12-31","value":-31588.59,"profit":false},{"date":"2022-12-31","value":-709,"profit":false},{"date":"2023-12-31","value":-650,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

QNRX
Cash Ratio 2.97
Current Ratio 3.02

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

QNRX
ROA (LTM) -36.32%
ROE (LTM) -100.03%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

QNRX
Debt Ratio Lower is generally better. Negative is bad. 0.52
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.48

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

QNRX
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 0.72
Price/FCF NM
EV/R 0.00
EV/Ebitda NM

FAQs

What is Quoin Pharmaceuticals Ltd DRC share price today?

Quoin Pharmaceuticals Ltd DRC (QNRX) share price today is $0.77

Can Indians buy Quoin Pharmaceuticals Ltd DRC shares?

Yes, Indians can buy shares of Quoin Pharmaceuticals Ltd DRC (QNRX) on Vested. To buy Quoin Pharmaceuticals Ltd DRC from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in QNRX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Quoin Pharmaceuticals Ltd DRC be purchased?

Yes, you can purchase fractional shares of Quoin Pharmaceuticals Ltd DRC (QNRX) via the Vested app. You can start investing in Quoin Pharmaceuticals Ltd DRC (QNRX) with a minimum investment of $1.

How to invest in Quoin Pharmaceuticals Ltd DRC shares from India?

You can invest in shares of Quoin Pharmaceuticals Ltd DRC (QNRX) via Vested in three simple steps:

  • Click on Sign Up or Invest in QNRX stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Quoin Pharmaceuticals Ltd DRC shares
What is Quoin Pharmaceuticals Ltd DRC 52-week high and low stock price?

The 52-week high price of Quoin Pharmaceuticals Ltd DRC (QNRX) is $5.33. The 52-week low price of Quoin Pharmaceuticals Ltd DRC (QNRX) is $0.48.

What is Quoin Pharmaceuticals Ltd DRC price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Quoin Pharmaceuticals Ltd DRC (QNRX) is

What is Quoin Pharmaceuticals Ltd DRC price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Quoin Pharmaceuticals Ltd DRC (QNRX) is 0.72

What is Quoin Pharmaceuticals Ltd DRC dividend yield?

The dividend yield of Quoin Pharmaceuticals Ltd DRC (QNRX) is 0.00%

What is the Market Cap of Quoin Pharmaceuticals Ltd DRC?

The market capitalization of Quoin Pharmaceuticals Ltd DRC (QNRX) is $3.94M

What is Quoin Pharmaceuticals Ltd DRC’s stock symbol?

The stock symbol (or ticker) of Quoin Pharmaceuticals Ltd DRC is QNRX

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top